Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Jones

Showing results (211-220 of 393) with videos related to

Pageof 40
Sort By:
Cancer Chemotherapy and Pharmacology|November 9, 2018
Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcomaRobin L Jones, Gary Mo, John R Baldwin, et al.
Anticancer Research|December 8, 2020
Efficacy of Gemcitabine-based Chemotherapy in Clear Cell Sarcoma of Soft TissueElena Cojocaru, Khin Thway, Cyril Fisher, et al.
Cancers|March 13, 2024
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort StudySu Yin Lim, Laura Ferro-López, Elizabeth Barquin, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2015
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancerRobin L Jones, Johanna C Bendell, David C Smith, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 21, 2006
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissueJorge S Reis-Filho, Dawn Steele, Silvana Di Palma, et al.
ESMO Open|July 19, 2018
2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcomaAnna Maria Frezza, Alex T J Lee, Eran Nizri, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 27, 2014
Analysis of clinical prognostic factors for adult patients with head and neck sarcomasAmy E Chang, Xiaoyu Chai, Seth M Pollack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2024
Best Overall Response-Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCEJiangang Liu, David S Moura, Robin L Jones, et al.
Journal of Geriatric Oncology|May 26, 2019
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trialEugenie Younger, Karla Ballman, Yao Lu, et al.
Gynecologic Oncology|September 16, 2011
Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centersRoberta Sanfilippo, Federica Grosso, Robin L Jones, et al.
Pageof 40

Showing results (211-220 of 393) with videos related to

Sort By:
Pageof 40
Cancer Chemotherapy and Pharmacology|November 9, 2018
Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcomaRobin L Jones, Gary Mo, John R Baldwin, et al.
Anticancer Research|December 8, 2020
Efficacy of Gemcitabine-based Chemotherapy in Clear Cell Sarcoma of Soft TissueElena Cojocaru, Khin Thway, Cyril Fisher, et al.
Cancers|March 13, 2024
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort StudySu Yin Lim, Laura Ferro-López, Elizabeth Barquin, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2015
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancerRobin L Jones, Johanna C Bendell, David C Smith, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 21, 2006
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissueJorge S Reis-Filho, Dawn Steele, Silvana Di Palma, et al.
ESMO Open|July 19, 2018
2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcomaAnna Maria Frezza, Alex T J Lee, Eran Nizri, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 27, 2014
Analysis of clinical prognostic factors for adult patients with head and neck sarcomasAmy E Chang, Xiaoyu Chai, Seth M Pollack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2024
Best Overall Response-Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCEJiangang Liu, David S Moura, Robin L Jones, et al.
Journal of Geriatric Oncology|May 26, 2019
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trialEugenie Younger, Karla Ballman, Yao Lu, et al.
Gynecologic Oncology|September 16, 2011
Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centersRoberta Sanfilippo, Federica Grosso, Robin L Jones, et al.
Pageof 40